1. Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes
- Author
-
Enrique Torres-Rasgado, Maria Elena Hernandez-Hernandez, Jose R. Romero, Patricia Pulido-Perez, and Jorge Alberto Pondigo-de Los Angeles
- Subjects
Adult ,Male ,medicine.medical_specialty ,Clinical Biochemistry ,Population ,Renal function ,Type 2 diabetes ,Kidney ,Biochemistry ,Gastroenterology ,Internal medicine ,medicine ,Humans ,Diabetic Nephropathies ,Magnesium ,Hospital Mortality ,Renal Insufficiency, Chronic ,education ,Molecular Biology ,Survival analysis ,Aged ,Retrospective Studies ,Aged, 80 and over ,education.field_of_study ,SARS-CoV-2 ,business.industry ,Proportional hazards model ,Case-control study ,COVID-19 ,Kidney metabolism ,Middle Aged ,Prognosis ,medicine.disease ,Survival Analysis ,medicine.anatomical_structure ,Diabetes Mellitus, Type 2 ,Case-Control Studies ,Female ,business ,Biomarkers ,Glomerular Filtration Rate - Abstract
Patients with type 2 diabetes (T2D) and Latin American subjects in particular are at an increased risk of developing severe COVID-19 and mortality. Altered renal function and lower magnesium levels have been reported to play important roles in the pathophysiology of T2D. The aim of the study was to investigate the relationship between renal function, serum magnesium levels and mortality in T2D patients with COVID-19. In this retrospective study, we characterized 118 T2D and non-diabetic subjects hospitalized with COVID-19. Patients were clinically characterized and electrolyte, renal function and inflammatory markers were evaluated. Patients were grouped according to their estimated glomerular filtration rate (eGFR
- Published
- 2021
- Full Text
- View/download PDF